Chen J, Wall M (2014) Epidemiology and risk factors for idiopathic intracranial hypertension. Int Ophthalmol Clin 54:1–11

Article  PubMed  Google Scholar 

Mollan SP, Davies B, Silver NC, Shaw S, Mallucci CL, Wakerley BR et al (2018) Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry 89:1088–1100

Article  PubMed  Google Scholar 

Maffeis L, Dilena R, Guez S, Menni F, Bana C, Osnaghi S et al (2019) Pseudotumour cerebri associated with mycoplasma pneumoniae infection and treatment with levofloxacin: a case report. BMC Pediatr 19:4

Article  PubMed  PubMed Central  Google Scholar 

Alfieri A (2016) Levofloxacin and intracranial hypertension in a patient with spondylodiscitis: a case report. Insights Neurosurg. [Internet] [cited 2023 Jul 13];01. Available from: http://neurosurgery.imedpub.com/levofloxacin-and-intracranial-hypertension-ina-patient-with-spondylodiscitis-a-case-report.php?aid=17449. Accessed 4 Nov 2016

Angelette AL, Rando LL, Wadhwa RD, Barras AA, Delacroix BM, Talbot NC et al (2023) Tetracycline-, doxycycline-, minocycline-induced pseudotumor cerebri and esophageal perforation. Adv Ther 40:1366–1378

Article  CAS  PubMed  Google Scholar 

Cohen DN (1973) Intracranial hypertension and papilledema associated by nalidixic acid therapy. Am J Ophthalmol 76:680–682

Article  CAS  PubMed  Google Scholar 

Lardizabal DV (2009) Intracranial hypertension and levofloxacin: a case report. Headache J Head Face Pain 49:300–301

Article  Google Scholar 

van der Laan LE, Schaaf HS, Solomons R, Willemse M, Mohamed N, Baboolal SO et al (2016) Probable levofloxacin-associated secondary intracranial hypertension in a child with multidrug-resistant tuberculosis: pediatr. Infect Dis J 35:706–708

Article  Google Scholar 

Blanc P, Paupe A, Carbajal R, Lenclen R, Olivier-Martin M (1998) Hypertension intracrânienne bénigne après un traitement par péfloxacine. Arch Pédiatrie 5:930–931

Article  CAS  Google Scholar 

Deonna T, Guignard JP (1974) Acute intracranial hypertension after nalidixic acid administration. Arch Dis Child 49:743–743

Article  CAS  PubMed  PubMed Central  Google Scholar 

Milanlioglu A, Torlak P (2011) Intracranial hypertension and ciprofloxacin. Neurol India 59:302

Article  PubMed  Google Scholar 

Getenet JC, Croisile B, Vighetto A, Grochowicki M, Goudable B, Aimard G et al (2009) Idiopathic intracranial hypertension after ofloxacin treatment. Acta Neurol Scand 87:503–504

Article  Google Scholar 

Sodhi M, Sheldon CA, Carleton B, Etminan M (2017) Oral fluoroquinolones and risk of secondary pseudotumor cerebri syndrome: Nested case-control study. Neurology 89:792–795

Article  CAS  PubMed  Google Scholar 

Faillie JL (2019) Case–non-case studies: principle, methods, bias and interpretation. Therapies 74:225–232

Article  Google Scholar 

Azzouz B, Morel A, Kanagaratnam L, Herlem E, Trenque T (2019) Psoriasis after exposure to angiotensin-converting enzyme inhibitors: French pharmacovigilance data and review of the literature. Drug Saf 42:1507–1513

Article  CAS  PubMed  Google Scholar 

Patel K, Goldman JL (2016) Safety concerns surrounding quinolone use in children. J Clin Pharmacol 56:1060–1075

Article  CAS  PubMed  PubMed Central  Google Scholar